BeyondSpring Inc. Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest
BeyondSpring Inc. (BYSI) reported Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest of -$841.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity · last filed 2026-08-14
- BeyondSpring Inc. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$841.00K.
- BeyondSpring Inc. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$132.00K.
- BeyondSpring Inc. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$136.00K.
- BeyondSpring Inc. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2025-09-30 was $41.00K.
- BeyondSpring Inc. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2025 was -$242.00K.
- BeyondSpring Inc. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2024 was -$388.00K.
- BeyondSpring Inc. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2023 was -$922.00K.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$841.00K 10-Q · filed 2026-08-14 | -$973.00K 10-Q · filed 2026-08-14 | -$1.11M derived: sum of 3 quarters · filed 2026-08-14 | -$1.07M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$132.00K 10-Q · filed 2026-05-13 | -$268.00K derived: sum of 2 quarters · filed 2026-05-13 | -$227.00K derived: sum of 3 quarters · filed 2026-05-13 | -$299.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$136.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$95.00K derived: sum of 2 quarters · filed 2026-03-25 | -$167.00K derived: sum of 3 quarters · filed 2026-08-14 | -$242.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $41.00K 10-Q · filed 2025-11-12 | -$31.00K derived: sum of 2 quarters · filed 2026-08-14 | -$106.00K 10-Q · filed 2025-11-12 | -$296.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$72.00K 10-Q · filed 2026-08-14 | -$147.00K 10-Q · filed 2026-08-14 | -$337.00K derived: sum of 3 quarters · filed 2026-08-14 | -$420.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$75.00K 10-Q · filed 2026-05-13 | -$265.00K derived: sum of 2 quarters · filed 2026-05-13 | -$348.00K derived: sum of 3 quarters · filed 2026-05-13 | -$406.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$190.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$273.00K derived: sum of 2 quarters · filed 2026-03-25 | -$331.00K derived: sum of 3 quarters · filed 2026-03-25 | -$388.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | -$83.00K 10-Q · filed 2025-11-12 | -$141.00K derived: sum of 2 quarters · filed 2025-11-12 | -$198.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$58.00K 10-Q · filed 2025-08-13 | -$115.00K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$57.00K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | -$922.00K 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |